Documented historyWhere the story actually begins
Guillemin and Schally independently determined the structure of a hypothalamic releasing hormone in 1969. Salk’s account identifies that molecule as TRH and explains how the work contributed to the 1977 Nobel Prize. TRH remains Original Disciple VI while also holding the site’s office of Prophet.
Independent U.S. research teams · structure reported 1969
Book of the Canon · Comic scriptureThe laboratory legend
TRH delivered one tiny message to exactly the right office. It was only three amino acids long, yet it started a chain of memos so large the thyroid department worked all weekend.
This bold passage is invented comedy, not scientific or historical fact.Editorial recordProfile editorial revision: October 4, 2026Prepared under the Church of Peptides evidence standardEditorial review: Church of PeptidesIndependent clinical review: none to dateContent evidence reviewed: September 14, 2026
Evidence ledgerSources
- Salk Institute history
- 1977 Nobel announcement
- Salk Institute: Guillemin and TRH history
- FDA: protirelin ALS orphan-designation record
Fiction disclosure: The bold laboratory legend above is invented. The historical and scientific sections are intended as sourced summaries; no invented connective events were added to the documented history.
Educational entertainment only. Not medical advice, diagnosis, dosing guidance, or a recommendation to obtain or use a product.